Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1

Conditions

Ovarian Neoplasms 13Sarcoma 5Testicular Neoplasms 4Astrocytoma 4Wilms Tumor 3Optic Nerve Glioma 3Oligodendroglioma 3Neuroectodermal Tumors, Primitive, Peripheral 3Neuroblastoma 3Medulloblastoma 3Kidney Neoplasms 3Familial ependymoma 3Fallopian Tube Neoplasms 3Choroid Plexus Neoplasms 3Central Nervous System Neoplasms 3Triple Negative Breast Neoplasms 2Testicular Germ Cell Tumor 2Teratoma 2Ovarian Germ Cell Cancer 2Osteosarcoma 2Liver Neoplasms 2Head and Neck Neoplasms 2Glioma 2Breast Neoplasms 2Urinary Bladder Neoplasms 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma, Synovial 1Sarcoma, Endometrial Stromal 1Sarcoma, Alveolar Soft Part 1

Interventions

Doxorubicin 4Ifosfamide 3Radiotherapy 2Ipilimumab 2Filgrastim 2saracatinib 1perifosine 1pembrolizumab 1fludarabine 1brostallicin 1belinostat 1aldesleukin 1Trabectedin 1Temozolomide 1Sunitinib 1Ritonavir 1Nivolumab 1Mass Spectrometry 1Injections 1Indinavir 1Imatinib Mesylate 1Fluorouracil 1Cyclophosphamide 1Chromatography, High Pressure Liquid 1Chemotherapy, Adjuvant 1CTLA-4 Antigen 1BI 2536 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Histiocytoma, Malignant Fibrous × Temozolomide × Gynecologic × Clear all
NCT00003718 2014-01-06

Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma

National Cancer Institute (NCI)

Phase 2 Unknown
25 enrolled
GynecologicSarcoma

Malignant mesenchymal tumor, Hemangiopericytoma, Malignant, Chondrosarcoma, Extraskeletal Myxoid, Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Ovarian Neoplasms, Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial, Endometrial Neoplasms, Sarcoma, Endometrial Stromal, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡